A paper published in PLoS ONE (Empirical Study of Data Sharing by Authors Publishing in PLoS Journals) last week highlighted the very important issue of data sharing by authors after publication. The small study, of 10 papers published in PLoS Medicine and PLoS Clinical Trials, found that of ten requests for raw data, “three investigators [...]
Filed under: Access, Authors | Tagged: medical literature, open access, PLoS, reporting, research ethics | 3 Comments »
(cross posted from a blog made by Mark Patterson on the PLoS Blog)
As part of our ongoing article-level metrics program, we’re delighted to announce that all seven PLoS journals will now provide online usage data for published articles, going back to their date of original publication. With this addition, the suite of metrics on PLoS [...]
Filed under: Authors, General | Tagged: article level metrics, Usage data | Leave a Comment »
A recent report published by the UK Medical Research Council focusses on the frameworks for regulation of biomedical research in the Peoples’ Republic of China (PRC). The findings highlight many aspects in which ethical oversight for research is similar between PRC and the UK, but also demonstrate key differences of which researchers and funders should [...]
Filed under: Authors, PLoS Medicine's Daily Click | Tagged: china, clinical trials, ethics regulation, research ethics, stem cell research | Leave a Comment »
The following editorial will be published in the September issue of PLoS Medicine but is being posted on this blog today to coincide with the availability on the PLoS Medicine site of the ghostwriting documents released after our intervention in the Prempro case, which we received last week. They are posted in the form in [...]
Filed under: Authors, Ghostwriting, Public | Tagged: Ghostwriting, pharmaceutical industry, research ethics | 9 Comments »
Guest blog by Adriane Fugh-Berman
Arrangements are underway for posting the ghostwriting documents disclosed through the intervention of PLoS Medicine and the New York Times. While you look forward to exploring the parallel universe of ghostwriters, guest authors, and ghost handlers, PLoS Medicine will release selected documents on this blog.
Our story to date: Wyeth-Ayerst (“the client”) [...]
Filed under: Authors, Ghostwriting, Public | Tagged: Ghostwriting, medical literature, pharmaceutical industry | 3 Comments »
As mentioned in our guest blog on the Wyeth ghostwriting case, alongside The New York Times article are the released documents relating to a “case study” of ghostwriting outlined in the article. The documents explain how Wyeth used the medical communications company Design Write to outline and draft an article describing the hormone drugs as [...]
Filed under: Authors, Ghostwriting, Media, Public | Tagged: Ghostwriting, medical literature, pharmaceutical industry | 4 Comments »
Guest blog by Adriane Fugh-Berman
PLoS Medicine and the New York Times victorious in court; Public will have access to ghostwriting documents
A duo of standard-setting publications has achieved a stunning success in the battle to end industry tampering of medical literature. Fifteen hundred documents that contain unprecedented detail on how articles highlighting specific marketing messages are [...]
Filed under: Authors, Ghostwriting, Media, Public | Tagged: Ghostwriting, medical literature, pharmaceutical industry | 12 Comments »
In the last “Ask PLoS Medicine” post, we emphasized that the Creative Commons Attribution License – the form of copyright that PLoS journals publish under – allows for unrestricted creative re-use of material, providing that the author and journal are cited.
Before she left PLoS for pastures new, Nisha Doshi wrote the following blog on this [...]
Filed under: Access, Ask PLoS Medicine, Authors | Tagged: creative re-use, language and medicine, open access | Leave a Comment »
Today an Arkansas federal judge granted public access today to evidence that Wyeth Pharmaceuticals “ghostwrote” medical articles regarding its hormone therapy drug Prempro. Along with the New York Times, PLoS Medicine, represented by the law firm Public Justice, had sought to intervene in a court case of women bringing an action in relation to Prempro [...]
Filed under: Authors, Ghostwriting, Public | Tagged: Ghostwriting, medical literature, pharmaceutical industry | 1 Comment »
PLoS Medicine is fast approaching its fifth anniversary, and we’ve noticed that there are a number of recurring questions that get asked about the journal and about open-access publishing by authors, potential authors and readers.
We’ll post these frequently-asked questions in this “Ask PLoS Medicine” part of the Speaking of Medicine blog. They are typically the [...]
Filed under: Ask PLoS Medicine, Authors | Tagged: Creative Commons, creative re-use, language and medicine, open access | 1 Comment »
Pubcasts of PLoS Medicine papers Popular articles from PLoS MedicineBlog at WordPress.com. Theme: Digg 3 Column by WP Designer
